59865-13-3 (环孢素 A,Cyclosporin A)

环孢素 A;环孢素;环胞霉素 A;环胞菌素;抗生素S;环胞霉素;环孢菌素A;环孢菌素;环孢菌素 USP标准品;环孢菌素(环孢素);环孢菌素,环孢霉素A;环孢菌素A,Cyclosporin A,植物提取物,标准品,对照品;环孢菌素A标准品;环孢菌素标准品(JP);环孢霉素A;环孢霉素A 标准品;环孢霉素A,BR;环孢素 EP标准品;环孢素（环孢素A）;环孢素-A;环孢素A标准品;环孢素系统适用性 EP标准品;环胞霉素A 标准品;[(E)(2S,3R,4R)-3-羟基-4-甲基-2-(甲氨基)-6辛烯酰]-L-2氨基丁酰-N-甲基甘氨酰-N-甲基-L-亮氨酰-L-缬氨酰-N-甲基-L-亮氨酰-L-丙氨酰-D-丙氨酰-N-甲基-L-亮氨酰-N-甲基-L-亮氨酰-N-甲基-L-缬氨酰;环孢多肽A;环孢菌素分离度用混合物;环孢灵;环孢素分离度用混合物;环蒽孢A;赛斯平;山地明;出地明;抗生素S 7481F1;环孢菌素 环孢菌素 环孢素 环胞菌素;环孢素环孢菌素杂质;环孢菌素, 环孢素, 抗生素S 7481F1,环孢多肽A,环孢灵,出地明;环胞霉素A.环孢素A;环胞霉素A, 98%+;环孢菌素 A 溶液;环孢素A;

Cyclosporin A;Cyclosporin A (Cyclosporine ,Antibiotic S 7481F1,Ciclosporin A, Ramihyphin A,CsA);Cyclosporin A solution;CYCLOSPORIN A, TOLYPOCLADIUM INFLATUM;Cyclosporine;Cyclosporine A;Atopica;ciclosporin;ciclosporin A;Cipol N;Cyclosporin A from Tolypocladium inflatum;Cyclosporine Resolution Mixture;Neoplanta;Neoral;ol27-400;Optimmune;Restasis;s7481f1;sandimmun;sandimmun neoral;Sandimmun optoral;Cyclosporin;Antibiotic S 7481F1;Ciclosporine;Ciclosporinum;Ciclosporina;Sandimmune;Equoral;Gengraf;Consupren;Ramihyphin A;SangCyA;83HN0GTJ6D;MLS001333756;CSA;S-Neoral;Sang 35;DSSTox_CID_365;Ciclosporinum [INN-Latin];Ciclosporine [INN-French];Ciclosporina [INN-Spanish];DSSTox_RID_75541;Ciclosporin (Ciclo;Cyclospori;1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptide deriv.;30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-dipropan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Tox21_110667;VEVYE;(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,2;Pulminiq;1c5f;CYCLOSPORINE [VANDF];Cyclokat;OLO-400;Cyclo(((E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl)-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl);Consupren S;Cyclosporine;Ciclosporin;CYCLOSPORIN A [MI];Cyclosporin A, >=98.5% (TLC);MLS000028376;Cyclosporine [USAN];BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA;Tox21_110667_1;BDBM50022815;C62H111N11O12;Sang-35;NSC290193;PMATZTZNYRCHOR-CGLBZJNRSA-N;ST-603;SBI-0050230.P003;EX-A4110;MFCD00274558;DTXCID00365;NSC 290193;NCGC00164258-03;M01532;(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl);NCGC00164258-01;Papilock;30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone;Papilock Mini;CsA & IFN.alpha.;NCGC00164258-02;4jjm;Q-200913;CB-01-09 MMX;Arpimune ME;BRD-K03222093-001-01-8;S 7481F1;30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Vekacia;(R-(R*,R*-(E)))-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl);Cyclosporine microemulsion;Abrammune;NCGC00016890-01;(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-((1R,2R,E)-1-hydroxy-2-methylhex-4-en-1-yl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone;ATH-002;2wfj;Sang-2000;SCHEMBL4442;OL-27400;CICLOSPORIN [WHO-IP];104250-72-8;Mitogard;Prestwick_731;NCGC00093704-12;AKOS015969287;CAS-59865-13-3;Cyclosporin A & IFN.alpha.;BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA;Cyclosporin A, from Tolypocladium inflatum, >=95% (HPLC), solid;Tox21_301849;BP-28432;Cicloral (antibiotic);Prestwick2_000435;MLS002207033;(R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl);DB00091;OL-27-400;DTXSID0020365;HMS2096G12;HMS2089A09;CYCLOSPORINE [USP IMPURITY];CYCLOSPORINE [USP-RS];(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Imusporin;Sandimmune Neoral;30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Sigmasporin Microoral;Ikervis;CCRIS 1590;SR-01000780563-3;SDZ-OXL-400;2z6w;CICLOSPORIN [WHO-DD];BRD-K13533483-001-03-0;CHEBI:92233;Debio088;CHEMBL160;Zyclorin;NeuroSTAT;BC164336;CICLOSPORIN [MART.];Ciclosporina Germed;SMR000058578;CICLOSPORIN [EP MONOGRAPH];CicloMulsion;CEQUA;UNII-83HN0GTJ6D;VERKAZIA;BPBio1_000496;HMS2230M14;Ciclosporin, European Pharmacopoeia (EP) Reference Standard;Cyclosporine [USAN:USP];Cyclosporin A, VETRANAL(TM), analytical standard;Cipol-N;Cyclosporin A, from Tolypocladium inflatum, BioReagent, for molecular biology, >=95%;Ciclosporin;;Ciclosporin for system suitability, European Pharmacopoeia (EP) Reference Standard;HY-B0579;(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;HSDB 6881;CHEBI:4031;Prestwick3_000435;KS-1257;Zinograf ME;Ciclosporin [INN];CYCLOSPORINE [GREEN BOOK];SR-01000780563;CCG-208184;(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-pent-3-enyl]-3,6,9,18,24-pentaisobutyl-21-isopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32;MLS002153454;DE-076;CYA;(R-(R*,R*-(E)))-CYCLIC(L-ALANYL-D-ALANYL-N-METHYL-L-LEUCYL-N-METHYL-L-LEUCYL-N-METHYL-L-VALYL-3-HYDROXY-N,4-DIMETHYL-L-2-AMINO-6-OCTENOYL-L-.ALPHA.-AMINOBUTYRYL-N-METHYLGLYCYL-N-METHYL-L-LEUCYL-L-VALYL-N-METHYL-L-LEUCYL);OL 27-400;BSPBio_000450;SDCCGSBI-0050230.P004;Seciera;NCGC00255232-01;Sigmasporin;HMS1569G12;CYCLOSPORINE [IARC];C2408;(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone;Modusik-A;Cyclosporine manufacturer;GTPL1024;Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl);Cyclo[[(E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl];CYCLOSPORINE [USP MONOGRAPH];30-Ethyl-33-((E)-1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone;1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine];HMS3713G12;CICLOSPORINUM [WHO-IP LATIN];DRG-0275;Q367700;Nova-22007;SCHEMBL3491;59865-13-3;ANTIBIOTIC S-7481F1;CYCLOSPORINE [ORANGE BOOK];A832514;SDZ-OXL 400;NSC-290193;1cyn;CICLOSPORIN [JAN];CYCLOSPORINE [HSDB];Ciclosporin DT;Cyclosporine, United States Pharmacopeia (USP) Reference Standard;Cyclosporine, Pharmaceutical Secondary Standard; Certified Reference Material;AS-13319;KBio1_000871;FT-0603156;Spectrum4_001279;KBioSS_000780;5-(N-Methyl-D-valine)-cyclosporin A;KBioGR_001898;(3R,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;KBio2_005916;Spectrum3_001593;SY012000;SPBio_001467;KBio3_002686;AKOS024456385;HMS3654L18;NINDS_000871;Spectrum2_001484;Spectrum_000300;CHEBI:201431;HMS3267I20;HMS3372A06;DivK1c_000871;FT-0603155;FT-0701261;HB0220;KBio2_000780;NCGC00093704-11;NS00096465;KBio2_003348;HMS3651O16;AKOS015994720;AB00052450_02;IDI1_000871;NCGC00093704-01;A840608;US9090657, Cyclosporine A, 1;NSC_2909;C05086;SCHEMBL20475023;HMS1989P18;NCGC00093704-10;CHEBI:91802;HMS1791P18;Lopac0_000242;Pharmakon1600-01502202;PMATZTZNYRCHOR-IMVLJIQESA-N;NCGC00093704-06;NCGC00093704-09;Restasis (TN);HMS3412G21;Tox21_500242;SR-01000075490-1;NCGC00093704-08;BRD-A64290322-001-01-6;BSPBio_003186;HMS1921L20;3C152;Spectrum5_001628;SCHEMBL3490;NSC-758194;CAS_2909;HMS2092F06;LMPK14000003;EU-0100242;NCGC00093704-43;NCGC00093704-03;BDBM86672;Neoral (TN);D00184;NSC758194;BRD-A69815203-001-04-3;NCGC00093704-17;SPECTRUM1502202;LP00242;NCGC00093704-07;AKOS015895103;SR-01000075490-6;CCG-39214;HMS3676G21;Sandimmune (TN);Cyclosporine (USP);NCGC00260927-01;NCGC00093704-35;Ciclosporin (JP17);HMS502L13;BSPBio_001596;LS-15525;NP444;NS00003734;30-ethyl-33-[(E)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Helv Chim Acta 60: 1568 (1977);Gengraf (TN);SR-01000075490;BDBM172718;HMS3260B06;SR-01000075490-7;C 3662;SR-01000075490-3;NCGC00093704-04;CHEMBL386389;NCGC00093704-02;BRD-A69815203-001-05-0;NCGC00093704-05;GLXC-04692;

MFCD00274558

PMATZTZNYRCHOR-CGLBZJNRSA-N

1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1

O([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])/C(/[H])=C(\[H])/C([H])([H])[H])[C@@]1([H])C(N([H])[C@]([H])(C(N(C([H])([H])[H])C([H])([H])C(N(C([H])([H])[H])[C@]([H])(C(N([H])[C@]([H])(C(N(C([H])([H])[H])[C@]([H])(C(N([H])[C@@]([H])(C([H])([H])[H])C(N([H])[C@]([H])(C([H])([H])[H])C(N(C([H])([H])[H])[C@@]([H])(C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C(N(C([H])([H])[H])[C@]([H])(C(N(C([H])([H])[H])[C@]([H])(C(N1C([H])([H])[H])=O)C([H])(C([H])([H])[H])C([H])([H])[H])=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])=O)=O)=O)=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])=O)C([H])(C([H])([H])[H])C([H])([H])[H])=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])=O)=O)C([H])([H])C([H])([H])[H])=O

3647785

MFCD00274558

2941909000

3647785

3647785